人工智能计算机辅助诊断与放射科医生在乳腺X线筛查中假阳性与假阴性判读的差异与相似之处
该回顾性病例对照研究基于2008至2015年乳腺X线筛查队列,纳入714例乳腺癌患者和8029例随机健康对照,比较AI、第一阅片者和第二阅片者的假阳性与假阴性评估与年龄、密度、肿瘤组织学及侵袭性的关系。结果显示AI与放射科医生假阴性在高密度女性中的分布比例相似,双阅片模拟中AI联合放射科医生可降低假阳性;结论认为AI与放射科医生联合可能对高密度和年长女性提高敏感度具有互补作用。
要点
- AI与放射科医生假阴性评估在高密度女性中均占多数(AI 58%、RAD 1 64%、RAD 2 64%)。
- 双阅片模拟中,AI+RAD 1在年轻女性假阳性为3.4%,高于RAD 1+RAD 2的2.5%。
- 作者认为AI与放射科医生联合可能对高密度和年长女性提高敏感度具有互补作用。
核心结论
- 作者结论认为,假阴性评估最明显的下降见于55岁以上女性和高密度女性,AI与放射科医生联合可能对高密度和年长女性提高敏感度具有重要互补作用。
研究设计与样本
- 回顾性病例对照研究,基于2008至2015年乳腺X线筛查队列,最终研究人群包括714例诊断为乳腺癌女性的筛查检查和8029例随机选取的健康对照,对对照进行过采样以达到与源筛查队列相似的癌症比例。
关键影像表现/征象
- AI的假阴性评估在低密度和高密度女性中分别为53例(42%)和72例(58%)。
- RAD 1的假阴性评估在低密度和高密度女性中分别为59例(36%)和104例(64%)。
- RAD 2的假阴性评估在低密度和高密度女性中分别为47例(36%)和84例(64%)。
- AI的假阳性评估在低密度和高密度女性中分别为1820例(47%)和2016例(53%)。
- RAD 1的假阳性评估在低密度和高密度女性中分别为1568例(46%)和1834例(54%)。
诊断标准与关键数值
- 双阅片模拟中,RAD 1+RAD 2的假阳性评估在年轻和年长女性中分别为2828例(2.5%)和1554例(1.4%)。
- 双阅片模拟中,AI+RAD 1的假阳性评估在年轻和年长女性中分别为3850例(3.4%)和2940例(2.6%)。
- 双阅片模拟中,AI+RAD 2的假阳性评估在年轻和年长女性中分别为3430例(3%)和2772例(2.5%)。
- 导管癌的假阴性评估:AI CAD为79例(77%),RAD 1为120例(83%),RAD 2为96例(16%)。
临床应用与阅片要点
- 作者认为AI与放射科医生联合可能对高密度和年长女性提高敏感度具有互补作用。
- 作者指出结果突显了将AI整合进乳腺癌筛查的潜在影响,尤其在提高判读准确性方面。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to evaluate the false interpretations between artificial intelligence (AI) and radiologists in screening mammography to get a better understanding of how the distribution of diagnostic mistakes might change when moving from entirely radiologist-driven to AI-integrated breast cancer screening.
METHODS AND MATERIALS: This retrospective case-control study was based on a mammography screening cohort from 2008 to 2015. The final study population included screening examinations for 714 women diagnosed with breast cancer and 8029 randomly selected healthy controls. Oversampling of controls was applied to attain a similar cancer proportion as in the source screening cohort. We examined how false-positive (FP) and false-negative (FN) assessments by AI, the first reader (RAD 1) and the second reader (RAD 2), were associated with age, density, tumor histology and cancer invasiveness in a single- and double-reader setting.
RESULTS: For each reader, the FN assessments were distributed between low- and high-density females with 53 (42%) and 72 (58%) for AI; 59 (36%) and 104 (64%) for RAD 1 and 47 (36%) and 84 (64%) for RAD 2. The corresponding numbers for FP assessments were 1820 (47%) and 2016 (53%) for AI; 1568 (46%) and 1834 (54%) for RAD 1 and 1190 (43%) and 1610 (58%) for RAD 2. For ductal cancer, the FN assessments were 79 (77%) for AI CAD; with 120 (83%) for RAD 1 and with 96 (16%) for RAD 2. For the double-reading simulation, the FP assessments were distributed between younger and older females with 2828 (2.5%) and 1554 (1.4%) for RAD 1 + RAD 2; 3850 (3.4%) and 2940 (2.6%) for AI+RAD 1 and 3430 (3%) and 2772 (2.5%) for AI+RAD 2.
CONCLUSION: The most pronounced decrease in FN assessments was noted for females over the age of 55 and for high density-women. In conclusion, AI could have an important complementary role when combined with radiologists to increase sensitivity for high-density and older females.
ADVANCES IN KNOWLEDGE: Our results highlight the potential impact of integrating AI in breast cancer screening, particularly to improve interpretation accuracy. The use of AI could enhance screening outcomes for high-density and older females.
引用
- Salim M, Dembrower K, Eklund M, et al. Differences and similarities in false interpretations by AI CAD and radiologists in screening mammography. Br J Radiol. 2023. PMID: 37660400. doi:10.1259/bjr.20230210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。